3-Hydroxy Darifenacin(Mixture of Diastereomers)

• CAT Number: R013617
• CAS Number: 1285875-62-8
• Molecular Formula: C28H30N2O3
• Molecular Weight: 442.559
• Purity: ≥95%
• Synonyms: 1-[2-(2,3-Dihydro-3-hydroxy-5-benzofuranyl)ethyl]-α,α-diphenyl-3-pyrrolidineacetamide; UK 148993
• Storage: -20°C
• IUPAC Name: 2-[1-[2-(3-hydroxy-2,3-dihydro-1-benzofuran-5-yl)ethyl]pyrrolidin-3-yl]-2,2-diphenylacetamide
• InChI: InChI=1S/C28H30N2O3/c29-27(32)28(21-7-3-1-4-8-21,22-9-5-2-6-10-22)23-14-16-30(18-23)15-13-20-11-12-26-24(17-20)25(31)19-33-26/h1-12,17,23,25,31H,13-16,18-19H2,(H2,29,32)
• InChIKey: MQEQBFMESJKUBQ-UHFFFAOYSA-N
• SMILES: C1CN(CC1C(C2=CC=CC=C2)(C3=CC=CC=C3)C(=O)N)CCC4=CC5=C(C=C4)OCC5O

3-Hydroxy Darifenacin (Mixture of Diastereomers) is a metabolite of darifenacin, used in pharmaceutical research. It is important for studying the pharmacokinetics, pharmacodynamics, and metabolic pathways of darifenacin, a drug used to treat overactive bladder. This compound aids in understanding the drug’s mechanism of action and optimizing therapeutic efficacy. Researchers rely on 3-Hydroxy Darifenacin for precise and reliable results in advanced drug development and metabolic studies, contributing significantly to advancements in urological treatments.